West Bancorporation Inc Amgen Inc Transaction History

West Bancorporation Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 14.6%	117 $28,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $13,375 - $14,796	-61 Reduced 30.81%	137 $33,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $2,187 - $2,503	-11 Reduced 5.26%	198 $45,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $15,721 - $17,483	-67 Reduced 24.28%	209 $53,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $52,221 - $67,123	276 New	276 $67,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

Stay updated on West Bancorporation Inc with notifications on news.